Accelerate Drug Discovery
with AI Agents Built for Scientists

Solves the Haystack Problem — automating evidence synthesis across 41+ databases to generate and validate novel drug targets in hours, not months.

Bridges the Translation Gap — automating protein, antibody, and small molecule drug design to reduce preclinical failure rates.

Addresses Late-Stage Attrition — AI-assisted protocol design, digital twin simulation, and predictive patient recruitment.